PL2889371T3 - Bacteroides cect 7771 i jego zastosowanie do zapobiegania i leczenia nadwagi, otyłości oraz zaburzeń metabolicznych i immunologicznych - Google Patents

Bacteroides cect 7771 i jego zastosowanie do zapobiegania i leczenia nadwagi, otyłości oraz zaburzeń metabolicznych i immunologicznych

Info

Publication number
PL2889371T3
PL2889371T3 PL13793926T PL13793926T PL2889371T3 PL 2889371 T3 PL2889371 T3 PL 2889371T3 PL 13793926 T PL13793926 T PL 13793926T PL 13793926 T PL13793926 T PL 13793926T PL 2889371 T3 PL2889371 T3 PL 2889371T3
Authority
PL
Poland
Prior art keywords
cect
bacteroides
obesity
metabolic
prevention
Prior art date
Application number
PL13793926T
Other languages
English (en)
Inventor
Yolanda Sanz Herranz
Paola GAUFFIN CANO
Yolanda Arlette SANTACRUZ
Ángela MOYA PÉREZ
Moisés LAPARRA LLOPIS
Original Assignee
Consejo Superior De Investigaciones Científicas (Csic)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior De Investigaciones Científicas (Csic) filed Critical Consejo Superior De Investigaciones Científicas (Csic)
Publication of PL2889371T3 publication Critical patent/PL2889371T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
PL13793926T 2012-05-25 2013-05-16 Bacteroides cect 7771 i jego zastosowanie do zapobiegania i leczenia nadwagi, otyłości oraz zaburzeń metabolicznych i immunologicznych PL2889371T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES201230796A ES2436251B1 (es) 2012-05-25 2012-05-25 Bacteroides cect 7771 y su uso en la prevención y tratamiento de sobrepeso, obesidad y alteraciones metabólicas e inmunológicas.
EP13793926.0A EP2889371B1 (en) 2012-05-25 2013-05-16 Bacteroides cect 7771 and the use thereof in the prevention and treatment of excess weight, obesity and metabolic and immunological alterations
PCT/ES2013/070309 WO2013175038A1 (es) 2012-05-25 2013-05-16 Bacteroides cect 7771 y su uso en la prevención y tratamiento de sobrepeso, obesidad y alteraciones metabólicas e inmunológicas

Publications (1)

Publication Number Publication Date
PL2889371T3 true PL2889371T3 (pl) 2020-04-30

Family

ID=49623202

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13793926T PL2889371T3 (pl) 2012-05-25 2013-05-16 Bacteroides cect 7771 i jego zastosowanie do zapobiegania i leczenia nadwagi, otyłości oraz zaburzeń metabolicznych i immunologicznych

Country Status (6)

Country Link
US (2) US9636366B2 (pl)
EP (1) EP2889371B1 (pl)
CA (1) CA2913391C (pl)
ES (2) ES2436251B1 (pl)
PL (1) PL2889371T3 (pl)
WO (1) WO2013175038A1 (pl)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
EP2836224A4 (en) 2012-02-29 2015-12-16 Ethicon Endo Surgery Inc COMPOSITIONS OF BIOZOOSE AND RELATED METHODS
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CN103865844B (zh) * 2014-02-18 2015-12-09 浙江省农业科学院 单形拟杆菌l8及在降解琼胶或琼胶寡糖中的应用
WO2015166489A2 (en) 2014-04-28 2015-11-05 Yeda Research And Development Co. Ltd. Method and apparatus for predicting response to food
EP3202891B1 (en) * 2014-09-30 2021-07-28 Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine Uses of bacteroides in treatment or prevention of obesity or diabetes
CN107002022A (zh) * 2014-09-30 2017-08-01 上海交通大学医学院附属瑞金医院 拟杆菌在治疗或预防肥胖相关疾病中的用途
CA2964480A1 (en) 2014-10-31 2016-05-06 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
EP3400953A1 (en) 2014-12-23 2018-11-14 4D Pharma Research Limited Pirin polypeptide and immune modulation
AR103260A1 (es) 2014-12-23 2017-04-26 4D Pharma Res Ltd Modulación inmunitaria
EA201792547A1 (ru) * 2015-05-21 2018-04-30 Иеда Рисеч Энд Девелопмент Ко. Лтд. Популяции бактерий для стимуляции состояния здоровья
NZ737752A (en) 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
SMT201900588T1 (it) 2015-06-15 2019-11-13 4D Pharma Res Limited Blautia stercoris e wexlerae per uso nel trattamento di malattie infiammatorie ed autoimmuni
WO2016203221A1 (en) 2015-06-15 2016-12-22 4D Pharma Research Limited Compositions comprising bacterial strains
CN108513545B (zh) 2015-11-20 2020-11-03 4D制药研究有限公司 包含细菌菌株的组合物
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
WO2017091694A1 (en) 2015-11-24 2017-06-01 Memorial Sloan-Kettering Cancer Center Methods and compositions for identifying and treating subjects at risk for checkpoint blockade therapy associated colitis
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
ME03487B (me) 2016-03-04 2020-01-20 4D Pharma Plc Kompozicije koje sadrže blautia bakterijske sojeve za liječenje visceralne hipersenzitivnosti
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
FR3062396A1 (fr) * 2017-01-27 2018-08-03 Ninapharm Composition de metabolites issus de la fermentation d'ingredients bio-sources a partir de microbiotes de centenaires ayant des proprietes anti-inflammatoires et d'augmentation de l'activite mitochondriale
DK3630136T3 (da) 2017-05-22 2021-05-25 4D Pharma Res Ltd Sammensætninger, der omfatter bakteriestammer
EP3630942B1 (en) 2017-05-24 2022-11-30 4D Pharma Research Limited Compositions comprising bacterial strain
SMT202000695T1 (it) 2017-06-14 2021-01-05 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
SMT202000555T1 (it) 2017-06-14 2020-11-10 4D Pharma Res Limited Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi
CA3066189A1 (en) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
WO2019041141A1 (zh) 2017-08-29 2019-03-07 深圳华大基因研究院 解纤维素拟杆菌在制备预防和/或治疗脂质代谢相关疾病制剂中的应用
JP2020532515A (ja) 2017-08-30 2020-11-12 ペンデュラム セラピューティクス， インコーポレイテッド マイクロバイオーム関連障害の処置のための方法および組成物
JP7378085B2 (ja) * 2017-10-03 2023-11-13 慶應義塾 体力向上作用及び抗疲労作用のうちの一以上の作用を有する組成物
WO2019166533A1 (en) * 2018-03-01 2019-09-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for prognosing and treating metabolic diseases
EP3823651A4 (en) 2018-07-19 2022-04-27 Pendulum Therapeutics, Inc. METHODS AND COMPOSITIONS FOR MICROBIAL TRANSPLANTATION
ES2769628B2 (es) * 2018-12-26 2020-11-25 Consejo Superior Investigacion Bacteria de Holdemanella sp. y uso de la misma
JPWO2021079869A1 (pl) * 2019-10-21 2021-04-29
US20230026402A1 (en) * 2019-10-22 2023-01-26 Cornell University Microbiota based therapies to promote mental health
ES2886646B2 (es) * 2020-06-17 2022-06-22 Consejo Superior Investigacion Cepa del genero bacteroides para su uso en el tratamiento y/o prevencion de trastornos alimentarios
CN113355271B (zh) * 2021-08-10 2021-11-09 中国农业大学 提高乳酸菌酸胁迫抗性的方法及其应用
JP2025533479A (ja) * 2022-09-16 2025-10-07 マーベルバイオーム・インコーポレイテッド インスリン関連疾患を治療するための方法、及び微生物叢組成物、成分、または代謝産物の使用
CN117045686B (zh) * 2023-10-08 2024-02-13 首都医科大学附属北京友谊医院 解纤维素拟杆菌在制备药物中的应用
CN120485307B (zh) * 2025-07-03 2025-10-31 中国海洋大学 一种萨利尔斯氏拟杆菌csp6来源的荚膜多糖及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2102350A4 (en) 2006-12-18 2012-08-08 Univ St Louis DARMMICROBIOMA AS A BIOMARKER AND THERAPEUTIC OBJECT FOR THE TREATMENT OF ADIPOSITAS OR ADIPOSITASCONDUCTIVE DISEASES
EP2211879B1 (en) * 2007-10-26 2014-05-07 Brenda E. Moore Probiotic compositions and methods for inducing and supporting weight loss
FR2955774A1 (fr) * 2010-02-02 2011-08-05 Aragan Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
TWI572354B (zh) * 2010-09-09 2017-03-01 明治股份有限公司 抑制發炎之組成物

Also Published As

Publication number Publication date
EP2889371B1 (en) 2019-10-16
WO2013175038A1 (es) 2013-11-28
EP2889371A1 (en) 2015-07-01
US20150216913A1 (en) 2015-08-06
EP2889371A4 (en) 2016-03-16
CA2913391C (en) 2021-06-01
CA2913391A1 (en) 2013-11-28
ES2764785T3 (es) 2020-06-04
US9636366B2 (en) 2017-05-02
ES2436251B1 (es) 2014-10-08
US20170189456A1 (en) 2017-07-06
ES2436251A1 (es) 2013-12-27

Similar Documents

Publication Publication Date Title
PL2889371T3 (pl) Bacteroides cect 7771 i jego zastosowanie do zapobiegania i leczenia nadwagi, otyłości oraz zaburzeń metabolicznych i immunologicznych
GB2478595B (en) Phytocannabinoids in the treatment of glioma
GB201120993D0 (en) Novel compounds and their use in therapy
SG10201602663RA (en) Chromosomal landing pads and related uses
GB2501611B (en) Alpha-2-macroglobulin compositions and therapeutic uses
PT2854910T (pt) Níveis de ceramida no tratamento e prevenção de infeções
EP2900266A4 (en) TOLL-LIKE RECEPTOR-3 ANTAGONISTS FOR THE TREATMENT OF METABOLISM AND CARDIAC DISEASES
SMT201800604T1 (it) Composti per il trattamento di obesita' e metodi di uso degli stessi
IL238126A0 (en) Compositions for the treatment and prevention of obesity
IL233875A0 (en) A preparation and its use for the treatment of anal fissures
LT2845598T (lt) Preparatas, skirtas naudoti netipinės osteoporozės prevencijai ir gydymui
GB201105915D0 (en) The hand and wrist physiotherapy prosthesis
IL237400A0 (en) Rhizobacteria and its uses
SG11201500838UA (en) Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof
IL230751A0 (en) New peptides, preparations containing them and used in methods to treat metabolic, cardiac and immune diseases
IL235066A0 (en) Sorcs1 for use in the treatment of obesity and overweight
PT2699545T (pt) Novos derivados amino-pirrolínicos, sua utilização na prevenção e/ou tratamento do síndrome metabólico
GB201022068D0 (en) The back straps of clothing
GB201209296D0 (en) 'Flip and Walk'
GB201307224D0 (en) Rucksack straps that may have lines/no's next to lines so when adjusting straps they are perfectly balanced and symmetrical
IL229670A0 (en) Lightweight concrete for non-structural uses - "superthermal ar"
AU345486S (en) Alu' sling armchair
AU345490S (en) Full alu' stool
PT2389936E (pt) Aminaftona para utilização no tratamento e/ou prevenção de enxaqueca
GB201303902D0 (en) Official's hawk